Alfavision Overseas (India) Limited (BOM:531156)
India · Delayed Price · Currency is INR 4.890
-0.010 (-0.20%)
At close: Jan 22, 2026
BOM:531156 Revenue
Alfavision Overseas (India) had revenue of 18.22M INR in the twelve months ending September 30, 2025, down -33.45% year-over-year. In the fiscal year ending March 31, 2025, Alfavision Overseas (India) had annual revenue of 19.06M, down -39.05%.
Revenue (ttm)
18.22M
Revenue Growth
-33.45%
P/S Ratio
8.41
Revenue / Employee
2.02M
Employees
9
Market Cap
153.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19.06M | -12.21M | -39.05% |
| Mar 31, 2024 | 31.27M | -276.84M | -89.85% |
| Mar 31, 2023 | 308.11M | -1.51B | -83.03% |
| Mar 31, 2022 | 1.82B | 24.74M | 1.38% |
| Mar 31, 2021 | 1.79B | 221.17M | 14.09% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.20B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 329.60M |
| Krebs Biochemicals & Industries | 272.16M |
| Link Pharma Chem | 258.97M |
| Crestchem | 242.52M |